主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GLMD
#4053
Galmed Pharmaceuticals Ltd.
0.6
1
-7.58%
版块:
基础:
利润货币:
日范围
年范围
日变化
-7.58%
每月变动
-28.24%
6个月变化
-56.74%
年变化
-72.27%
前一天收盘价
0.6
6
Open
0.6
1
Bid
Ask
Low
0.6
1
High
0.6
1
交易量
2
市场
股票
医疗保健
GLMD
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
118.48 K
139.38 K
140.02 K
420.44 K
1.65 M
2.35 M
Valuation ratios
Enterprise value
—
—
—
—
577.63 K
—
Price to earnings ratio
—
—
—
—
0.39
—
Price to sales ratio
—
—
—
—
74.23
—
Price to cash flow ratio
—
—
—
—
0.5
—
Price to book ratio
—
—
—
—
0.18
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.55
0.89
1.08
0.42
0.41
-0.85
Return on equity %
0.65
1.06
1.33
0.5
0.46
-1.02
Return on invested capital %
402.77
-749.41
-3 585.75
-898.44
-517.57
—
Gross margin %
—
-477.9
100
100
100
—
Operating margin %
—
-132 K
-48.93 K
-17.15 K
-15.59 K
—
EBITDA margin %
—
-131.83 K
—
—
—
—
Net margin %
—
129.87 K
49.63 K
15.71 K
18.79 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.47
6.13
4.76
4.81
7.42
23.13
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.03
0.03
0.05
0.05
0.16
Long term debt to total equity ratio
—
0.03
0.04
0.06
0.05
0.19
Per share metrics
Operating cash flow per share
—
240.7
132.45
26.59
6.32
-105.21
EBIT per share
—
-241.49
—
—
—
—
EBITDA per share
—
-241.18
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
254.54
98.8
45.06
12.78
411.18
Net current asset value per share
—
263.84
105.41
57.36
17.32
443.93
Tangible book value per share
—
223.17
96.1
60.14
17.54
396.94
Working capital per share
—
220.81
83.26
45.45
14.99
364.51
Book value per share
—
223.17
96.1
60.14
17.54
396.94
新闻
Galmed Pharmaceuticals将于3月4日召开特别股东大会
Galmed Pharmaceuticals schedules special shareholder meeting for March 4
Galmed制药收到纳斯达克最低竞价通知
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice
Galmed将展示Aramchol在肝癌治疗中的潜力数据
Galmed to present data on Aramchol’s potential in liver cancer
Galmed制药股价在获得MASH联合疗法专利后上涨
Galmed stock rises after patent grant for MASH combo therapy
高尔美德制药在韩国获得组合疗法专利
Galmed receives patent for combination therapy in South Korea
Galmed制药公司股价因CEO多方展望而上涨
Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook